Global equine healthcare market is anticipated to grow at a CAGR of 6.1% during the forecast period (2024-2031). In recent times, there have been many reforms on tough animal treatment policies emphasized by many states in the US. The well-being of equines is crucial as they largely contribute to the agriculture, and sports industries among others. In addition rising concerns about the extension of contagions amid horses have made governments put more funds into surveillance and control plans aimed at strengthening the equine healthcare market.
Browse the full report description of “Equine Healthcare Market Size, Share & Trends Analysis Report by Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus and Others), by Product (Vaccines, Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory & Analgesics), Medicinal Feed Additives, Diagnostics, and Others), and by Distribution Channel (Veterinary hospital pharmacies and E-commerce) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/equine-healthcare-market
In March 2023, Zoetis unveiled the integration of two novel functionalities, AI dermatology and AI equine FEC analysis, into its versatile diagnostic platform, Vetscan Imagyst™. These innovative diagnostic enhancements facilitate the expansion of Vetscan Imagyst's testing capabilities beyond Zoetis' established AI canine and feline fecal analysis services.
In September 2022, Zoetis completed the acquisition of NewMetrica, an esteemed animal health research institute. This strategic move is geared towards pioneering innovative methodologies aimed at advancing veterinary care and promoting animal welfare on a broader spectrum. The focus lies on enhancing the quality of life and fostering exceptional standards of care for companion animals.
In April 2022, Boehringer Ingelheim International GmbH introduced renuTend, an innovative stem cell therapy crafted to augment the recovery process of tendon and suspensory ligament injuries in equines. This launch offers veterinarians a new therapeutic option for managing conditions associated with tendons and suspensory ligaments.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Indication
o By Product
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Bayer AG, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Virbac S.A., and Zoetis Services LLC, among others.
Key questions addressed by the report.
Global Equine Healthcare Market Report Segment
By Indication
By Product
By Distribution Channel
Global Equine Healthcare Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/equine-healthcare-market